Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosok, M. J.
Right arrow Articles by Glaser, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosok, M. J.
Right arrow Articles by Glaser, S. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 37, Issue of September 13, 1996 pp. 22611-22618
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

A Combinatorial Library Strategy for the Rapid Humanization of Anticarcinoma BR96 Fab

(Received for publication, April 19, 1996, and in revised form, June 25, 1996)

Mae Joanne Rosok Dagger , Dale E. Yelton Dagger , Linda J. Harris Dagger , Jürgen Bajorath Dagger , Karl-Erik Hellström Dagger , Ingegerd Hellström Dagger , Gina A. Cruz , Karin Kristensson , Huey Lin , William D. Huse and Scott M. Glaser

From Dagger  Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121 and  Ixsys, Inc., San Diego, California 92121

We have used a combinatorial mutagenesis strategy to humanize BR96, a monoclonal antibody that binds to the Lewis Y class of tumor antigens. This approach allows simultaneous assessment of hundreds of humanized variable regions to identify the molecules that best preserve affinity, thus overcoming the major drawback of current humanization procedures, the requirement to construct and analyze each humanized antibody separately. Murine residues of BR96 were mutated to human if they were solvent-exposed residues that did not participate in the formation of the antigen binding site and were not at the interface of the light and heavy chain. At positions that might be involved in binding to antigen, the choice between the murine and human residue was more difficult. Murine and human alternatives were incorporated into a combinatorial library at positions representing buried residues that might affect the structural integrity of the antigen binding site. By encoding this library of humanized BR96 Fabs in an M13 phage vector, we rapidly identified several candidates with nearly identical antigen binding, within 2-fold, of the chimeric Fab. Additional mutagenesis directed at sites suggested in the literature as potentially important for antigen binding in a similar anti-Lewis Y antibody yielded no further improvements.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
X. Cheng, Y. Zhang, N. Kotani, T. Watanabe, S. Lee, X. Wang, I. Kawashima, T. Tai, N. Taniguchi, and K. Honke
Production of a Recombinant Single-Chain Variable-Fragment (scFv) Antibody against Sulfoglycolipid
J. Biochem., March 1, 2005; 137(3): 415 - 421.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
C. Caldas, V. P.C.V. Coelho, D. J. Rigden, G. Neschich, A. M. Moro, and M. M. Brigido
Design and synthesis of germline-based hemi-humanized single-chain Fv against the CD18 surface antigen
Protein Eng. Des. Sel., May 1, 2000; 13(5): 353 - 360.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Rader, G. Ritter, S. Nathan, M. Elia, I. Gout, A. A. Jungbluth, L. S. Cohen, S. Welt, L. J. Old, and C. F. Barbas III
The Rabbit Antibody Repertoire as a Novel Source for the Generation of Therapeutic Human Antibodies
J. Biol. Chem., April 28, 2000; 275(18): 13668 - 13676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Tang, G. Beuerlein, G. Pecht, T. Chilton, W. D. Huse, and J. D. Watkins
Use of a Peptide Mimotope to Guide the Humanization of MRK-16, an Anti-P-glycoprotein Monoclonal Antibody
J. Biol. Chem., September 24, 1999; 274(39): 27371 - 27378.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Rader, D. A. Cheresh, and C. F. Barbas III
A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries
PNAS, July 21, 1998; 95(15): 8910 - 8915.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Wu, G. Beuerlein, Y. Nie, H. Smith, B. A. Lee, M. Hensler, W. D. Huse, and J. D. Watkins
Stepwise in vitro affinity maturation of Vitaxin, an alpha vbeta 3-specific humanized mAb
PNAS, May 26, 1998; 95(11): 6037 - 6042.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Rosok, M. Eghtedarzadeh-Kondri, K. Young, J. Bajorath, S. Glaser, and D. Yelton
Analysis of BR96 Binding Sites for Antigen and Anti-Idiotype by Codon-Based Scanning Mutagenesis
J. Immunol., March 1, 1998; 160(5): 2353 - 2359.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Baca, L. G. Presta, S. J. O'Connor, and J. A. Wells
Antibody Humanization Using Monovalent Phage Display
J. Biol. Chem., April 18, 1997; 272(16): 10678 - 10684.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement